These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 2400866)

  • 1. Genetic screening for ethnic minorities.
    Bhavnani M
    BMJ; 1990 Aug 18-25; 301(6748):390. PubMed ID: 2400866
    [No Abstract]   [Full Text] [Related]  

  • 2. Genetic screening for ethnic minorities.
    Modell M; Modell B
    BMJ; 1990 Jun; 300(6741):1702-4. PubMed ID: 2390553
    [No Abstract]   [Full Text] [Related]  

  • 3. Couple screening to avoid thalassemia: successful in Iran and instructive for us.
    Haddow JE
    J Med Screen; 2005; 12(2):55-6. PubMed ID: 15949113
    [No Abstract]   [Full Text] [Related]  

  • 4. Validation of osmotic fragility test and dichlorophenol indophenol precipitation test for screening of thalassemia and Hb E.
    Sangkitporn S; Sangkitporn S; Sangnoi A; Supangwiput O; Tanphaichitr VS
    Southeast Asian J Trop Med Public Health; 2005 Nov; 36(6):1538-42. PubMed ID: 16610659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for beta-thalassaemias.
    Lancet; 1981 Sep; 2(8246):566. PubMed ID: 6116010
    [No Abstract]   [Full Text] [Related]  

  • 6. Prenatal diagnosis of beta-thalassemia.
    Kazazian HH
    Semin Perinatol; 1991 Jun; 15(3 Suppl 2):15-24. PubMed ID: 1887258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prenatal diagnosis of beta-thalassemia using genetic engineering techniques].
    Glaser G; Karsai A; Kerem H; Yarkoni S; Rachmilewitz E
    Harefuah; 1982 Dec; 103(11):293-4. PubMed ID: 7182334
    [No Abstract]   [Full Text] [Related]  

  • 8. The thalassemias and health care in Canada: a place for genetics in medicine.
    Chui DH; Wong SC; Scriver CR
    CMAJ; 1991 Jan; 144(1):21-3. PubMed ID: 1984811
    [No Abstract]   [Full Text] [Related]  

  • 9. Carrier screening for thalassemia and hemoglobinopathies in Canada.
    Langlois S; Ford JC; Chitayat D; ;
    J Obstet Gynaecol Can; 2008 Oct; 30(10):950-959. PubMed ID: 19038079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Classification, Screening and Diagnosis for Thalassemia.
    Viprakasit V; Ekwattanakit S
    Hematol Oncol Clin North Am; 2018 Apr; 32(2):193-211. PubMed ID: 29458726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening of beta-thalassemia mutations by PCR and ASO analysis in an Italian population of mixed geographic origin.
    Alfarano A; Gottardi E; Serra A; Piga A; Mandrino M; Mazza U; Camaschella C
    Haematologica; 1990; 75(6):506-9. PubMed ID: 2098291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A national screening policy for sickle cell disease and thalassaemia major for the United Kingdom. Questions are left after two evidence based reports.
    Streetly A
    BMJ; 2000 May; 320(7246):1353-4. PubMed ID: 10818007
    [No Abstract]   [Full Text] [Related]  

  • 13. Genetic counseling for thalassemia in the Islamic Republic of Iran.
    Strauss BS
    Perspect Biol Med; 2009; 52(3):364-76. PubMed ID: 19684371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Biochemical screening and genetic diagnosis of thalassemia in children from Kunming].
    Wen BP; Fan M; Dai HJ; Zhuang Y; Liu HL; Yang JY; Yang XH; Deng WG
    Zhongguo Dang Dai Er Ke Za Zhi; 2011 Feb; 13(2):104-6. PubMed ID: 21342616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HbVar database of human hemoglobin variants and thalassemia mutations: 2007 update.
    Giardine B; van Baal S; Kaimakis P; Riemer C; Miller W; Samara M; Kollia P; Anagnou NP; Chui DH; Wajcman H; Hardison RC; Patrinos GP
    Hum Mutat; 2007 Feb; 28(2):206. PubMed ID: 17221864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Micromapping of thalassemia and hemoglobinopathies in diferent regions of northeast Thailand and Vientiane, Laos People's Democratic Republic.
    Tritipsombut J; Sanchaisuriya K; Phollarp P; Bouakhasith D; Sanchaisuriya P; Fucharoen G; Fucharoen S; Schelp FP
    Hemoglobin; 2012; 36(1):47-56. PubMed ID: 22122810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of deletion and triple alpha-globin gene haplotypes in the Montreal beta-thalassemia screening program: implications for genetic medicine.
    Akerman BR; Fujiwara TM; Lancaster GA; Morgan K; Scriver CR
    Am J Med Genet; 1990 May; 36(1):76-84. PubMed ID: 2333910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The thalassemia repository.
    Lanclos KD; Kutler A
    Hemoglobin; 1986; 10(5):533-8. PubMed ID: 3781868
    [No Abstract]   [Full Text] [Related]  

  • 19. The pros and cons of the fourth revision of thalassaemia screening programme in Iran.
    Moafi A; Vallian R; Vallian S; Rahgozar S; Torfenajad M; Moafi H
    J Med Screen; 2017 Mar; 24(1):1-5. PubMed ID: 26992783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Silent beta-thalassemia and thalassemia intermedia.
    Huisman TH
    Haematologica; 1990; 75 Suppl 5():1-8. PubMed ID: 2086369
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.